Cargando…
Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging
Regadenoson myocardial perfusion imaging (MPI) is a widely used screening study for patients with an intermediate pretest probability of coronary artery disease (CAD). Via selective agonism of the adenosine A2A receptor, regadenoson can induce coronary steal, revealing stenotic vessel territory thro...
Autores principales: | Ahmad, Tanjeev, Linares, Juan, Valencia, Damian N, Agarwal, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075772/ https://www.ncbi.nlm.nih.gov/pubmed/33927915 http://dx.doi.org/10.7759/cureus.14091 |
Ejemplares similares
-
Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019) -
Serious complications associated with regadenoson administration for myocardial perfusion imaging
por: Kitt, Therese, et al.
Publicado: (2014) -
Regadenoson Stress Testing: A Comprehensive Review With a Focused Update
por: Elkholy, Karim O, et al.
Publicado: (2021) -
Positive Regadenoson Stress Test in a Patient on Phentermine With Normal Coronaries
por: Sendil, Selin, et al.
Publicado: (2022) -
Regadenoson Cardiac Stress Test-Induced Takotsubo Cardiomyopathy: A Case Report
por: Farid, Saira, et al.
Publicado: (2020)